We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$5.36B
AUM Growth
+$854M
Cap. Flow
+$792M
Cap. Flow %
14.77%
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$82.6M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$78.3M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$57.7M
4
TER icon
Teradyne
TER
+$56.1M
5
ABBV icon
AbbVie
ABBV
+$52.9M

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$66.1M
2
ZBH icon
Zimmer Biomet
ZBH
+$56.1M
3
NVDA icon
NVIDIA
NVDA
+$55.8M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$54.7M
5
EBAY icon
eBay
EBAY
+$40.9M

Sector Composition

Rank Sector Weight
1 Healthcare 46.89%
2 Technology 25.02%
3 Communication Services 8.75%
4 Financials 5.58%
5 Industrials 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSNB.WS
501
DELISTED
Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FSNB.WS
$106K ﹤0.01%
+108,330
New +$85.4K
KRNLW
502
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$104K ﹤0.01%
+100,000
New +$66.9K
PDOT.WS
503
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$101K ﹤0.01%
+90,000
New +$90.7K
MBAC.WS
504
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$100K ﹤0.01%
+86,606
New +$72.5K
AISPW
505
Airship AI Holdings Warrants
AISPW
$13.1M
$96K ﹤0.01%
+75,000
New +$58.5K
EFTRW
506
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
$94K ﹤0.01%
93,922
– –
ATHN.WS
507
DELISTED
Athena Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one shar
ATHN.WS
$94K ﹤0.01%
+108,333
New +$82K
AONCW
508
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$93K ﹤0.01%
+100,000
New +$79.8K
DHBCW
509
DELISTED
DHB Capital Corp. Warrant
DHBCW
$93K ﹤0.01%
+103,313
New +$75.4K
HIIIW
510
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$90K ﹤0.01%
+80,000
New +$75.8K
EBACW
511
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
$88K ﹤0.01%
+91,666
New +$85.3K
TSPQ.WS
512
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
$87K ﹤0.01%
+91,666
New +$70.7K
TETCW
513
DELISTED
Tech and Energy Transition Corporation Warrant
TETCW
$84K ﹤0.01%
+83,333
New +$69.6K
CLAA.WS
514
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$83K ﹤0.01%
+77,224
New +$71K
HERAW
515
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$83K ﹤0.01%
+62,500
New +$67.5K
LGACW
516
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$81K ﹤0.01%
+70,000
New +$74.6K
TBCPW
517
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$78K ﹤0.01%
+60,000
New +$62.1K
SCAQW
518
DELISTED
Stratim Cloud Acquisition Corp. Warrant
SCAQW
$76K ﹤0.01%
+91,666
New +$69.8K
TWNT.WS
519
DELISTED
Tailwind Two Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant
TWNT.WS
$75K ﹤0.01%
+75,000
New +$60.2K
BNAIW
520
Brand Engagement Network Warrant
BNAIW
$74K ﹤0.01%
+75,000
New +$62.3K
AFAQW
521
DELISTED
AF Acquisition Corp Warrants
AFAQW
$73K ﹤0.01%
+83,333
New +$63.5K
AAC.WS
522
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$72K ﹤0.01%
+57,333
New +$60.5K
AGAC.WS
523
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$71K ﹤0.01%
+112,500
New +$56.3K
PEARW
524
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$70K ﹤0.01%
+50,034
New +$43.7K
SBII.WS
525
DELISTED
Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
SBII.WS
$70K ﹤0.01%
+66,666
New +$57.5K
19 20
21
22 23

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

Woodline Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.

  • Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
  • Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
  • Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
  • Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
  • Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
  • Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
  • Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.

Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.